---
title: ReechPharma, LLC vs Voiant
slug_a: reechpharma
slug_b: voiantclinical
site: cro
review_signal_gate: closed
canonical_path: /compare/reechpharma/voiantclinical
---

# ReechPharma, LLC vs Voiant

Side-by-side profile data from each company listing on this directory.

## ReechPharma, LLC

- Profile: [/companies/reechpharma](/companies/reechpharma)

ReechPharma, LLC — ReechPharma specializes in customized formulation development and drug delivery systems for preclinical and clinical stages, supporting biotech and pharma companies with formulation research, analytical services, and GMP manufacturing.

Services: 11. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Preclinical In Vitro Studies
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- GLP Toxicology
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research

### Modalities

- Small Molecule

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Voiant

- Profile: [/companies/voiantclinical](/companies/voiantclinical)

Voiant — Voiant is the industry-leading imaging CRO for clinical trial imaging and endpoint adjudication, leveraging 30+ years of clinical expertise and AI-powered technology to deliver high-quality endpoint data across Phase I–IV global trials.

Services: 5. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Imaging Core Lab

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Data not yet provided.